Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies
Open Access

Acute Appendicitis During Coronavirus Disease 2019 (COVID-19): Increasing Incidence of Complicate Appendicitis, Severity and Length of Hospitalization

MARCO PELLICCIARO, GIANLUCA VANNI, SIMONA GRANDE, MARCO MATERAZZO, FRANCESCA SANTORI, TATIANA DI CESARE, MATTEO CIANCIO MANUELLI, DANIELE SFORZA, MASSIMO VILLA, DARIO VENDITTI and MICHELE GRANDE
In Vivo May 2022, 36 (3) 1325-1332; DOI: https://doi.org/10.21873/invivo.12833
MARCO PELLICCIARO
1Department of General and Emergency Surgery, University of Tor Vergata, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GIANLUCA VANNI
2Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University of Tor Vergata, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SIMONA GRANDE
1Department of General and Emergency Surgery, University of Tor Vergata, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARCO MATERAZZO
1Department of General and Emergency Surgery, University of Tor Vergata, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANCESCA SANTORI
1Department of General and Emergency Surgery, University of Tor Vergata, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TATIANA DI CESARE
3Surgical Emergency Unit, Emergency Department, Polyclinic Tor Vergata Foundation, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MATTEO CIANCIO MANUELLI
3Surgical Emergency Unit, Emergency Department, Polyclinic Tor Vergata Foundation, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DANIELE SFORZA
3Surgical Emergency Unit, Emergency Department, Polyclinic Tor Vergata Foundation, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASSIMO VILLA
1Department of General and Emergency Surgery, University of Tor Vergata, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DARIO VENDITTI
1Department of General and Emergency Surgery, University of Tor Vergata, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHELE GRANDE
1Department of General and Emergency Surgery, University of Tor Vergata, Rome, Italy;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: COVID-19 is rapidly spreading, and due to the high morbidity and mortality caused by the pandemic many Governments have introduced social restrictions. Those measures combined with infection-related patient anxiety, led to hiding other diseases. The aim of this study was to evaluate the impact of COVID-19 on numbers and severity of acute appendicitis cases referred during the pandemic. Patients and Methods: Between March 2019 and March 2021, all patients who underwent appendectomy in Tor Vergata Hospital, Rome were included. Patients were divided in two groups (COVID-19/pre-COVID-19). Clinical features, intraoperative findings, hospital stay, and histologic examination data were included in the retrospective analysis. Results: Out of 334 admitted patients, 36 (10.7%) had a diagnosis of acute appendicitis (COVID-19 group) vs. 59(11.2%) in the pre-COVID-19 group. The COVID-19 group presented significantly longer hospitalization, incidence of appendicular abscess, perforation, and severity of inflammation at univariate analysis p=0.002, p=0.021, p=0.001, p=0.006, p=0.001, respectively. At multivariate analysis, appendicular abscess (p=0.015) and higher serum levels of C reactive protein (p<0.008) were associated with prolonged hospital stay. Conclusion: This study highlights the correlation between COVID-19 pandemic and the severity of acute appendicitis presentations.

  • Acute appendicitis
  • COVID-19
  • SARS-CoV-2
  • occult disease
  • appendectomy
  • peritonitis

Since the first cases of SARS-CoV-2 infection were described in Wuhan, Hubei province, China, during late 2019, the new coronavirus rapidly spread worldwide causing an unusual type of pneumonia (1). Due to extremely rapid human-to-human transmission, on March 11, 2020, the World Health Organization declared the outbreak of a global pandemic (1-2). Many governments struggled to intercept the spread of SARS-CoV-2 by utilizing different strategies (3).

Healthcare systems shifted resources towards COVID-19 patients and adopted measures to preserve hospital capacity and increase intensive care unit beds availability during the emergency (3). These restrictions have been associated with a decrease in or cessation of most non-COVID-19 health services with a significant impact on daily practices (4-5). In addition, authorities instructed the public to stay at home and avoid visiting local clinics and hospitals as much as possible while recommending increased application of telemedicine-based practice (6). Moreover, infection-related patient anxiety played a major role in avoiding hospitalization or access to healthcare facilities (7-9). Potentially, all these factors combined led to hidden disease (10) and delayed diagnoses and treatments (11, 12). Nonetheless, urgent or emergent medical conditions continue to appear during the current outbreak and diagnoses should still be made promptly. Delayed diagnosis and treatment of non-COVID-19 disease can lead to significant morbidity that may overweigh the harm caused by SARS-CoV-2 infection (13, 14).

While most published studies regarding SARS-CoV-2 infection have explored viral transmission, pathogenesis, treatments and outcomes, the effective impact on other disease requires further investigation (15-17).

Acute appendicitis represents 4.5% of abdominal pain occurrences and the most common emergency any general surgeon faces in practice (18, 19). In western countries, the lifetime risk of acute appendicitis is calculated to be 1 in 15 individuals (19). Severity and associated morbidity can be correlated with the period between signs and symptoms onset to treatment initiation (19).

We hypothesize that COVID-19 restrictions have resulted in a significant impact on the number of patients presenting to the Emergency Department with a diagnosis of acute appendicitis. Moreover, patients admitted to the emergency department present with advanced stages and severity of the disease due to pandemic-related delayed diagnoses and treatments.

The aim of the study was to evaluate the impact of COVID-19 on number, severity, and length of hospitalization of acute appendicitis patients treated during the pandemic.

Patients and Methods

The study was conducted as a retrospective, cohort investigation of acute appendicitis patients undergoing surgery at Policlinico Tor Vergata hospital of Rome, Italy. The study was approved by the local Ethical Committee of Fondazione Policlinico Tor Vergata (reference 122/20). The requirement for informed consent was waived by the committee in light of the retrospective and anonymous nature of the study.

All patients admitted to the surgical Emergency Department with a suspicion of acute appendicitis, and consequently undergone appendicectomy between March 11, 2019, and March 11, 2021 were identified and data were collected for the analysis.

Data were extracted from patient records and included demographic and clinicopathological variables. White blood cells (WBCs) count, percentage of neutrophils and C reactive protein (CRP) value collected from blood test performed at hospital admission were reported for each patient (20). Number of previous hospital admissions due to conservatively-treated acute appendicitis were reported. Signs, symptoms, and duration between the onset of symptomatology and admission to healthcare were reported as well. Alvarado scores were calculated and reported for the analysis (21). The performed radiological exam, abdominal CT scan or sonography in unclear cases, were reported. Surgical data for analysis were collected from surgical procedure notes. Surgical procedure duration was reported in minutes and the surgical approach was distinguished between laparoscopic appendectomy, open appendectomy or converted. Severity of appendicitis was reported according to surgical notes; presence of peritonitis and number of abdominal quadrantes involved in the phlogistic process, presence of free fluid in abdomen and its type (e.g., exudative, pus or faecalis), reported as categorial variables. Additionally, perforation of the appendix and/or presence on abdominal abscesses detected during the abdominal exploration were reported. Methods for closure of appendix stump were reported as categorial variables (e.g., endo loop knots, surgical suture, or automated mechanical suture). Need for abdominal surgical drainage or re-operation, and related causes were collected and analyzed. The report included whether the surgical procedure was performed by a trainee or a senior surgeon. WBCs count, percentage of neutrophils and value of CRP collected from the first blood test performed after surgery were recorded. Types of appendicitis were reported from pantological examination of the appendix, performed routinely by an expert pathologist, and categorized as: inflamed, acute suppurative, gangrenous and necrotic. Length of hospital stay was considered from the date of the surgical procedure to hospital discharge, reported in days.

The goal of the study was to compare the incidence of acute appendicitis before and during the pandemic and evaluate changes in the characteristics or severity of patients diagnosed with appendicitis during the COVID-19 emergency compared to beforehand.

In order to assess these aims, our cohort was split into two different groups. Patients presenting in the 12 months prior to the declaration of pandemic were designated as pre-COVID-19 group, while those presenting in the following 12 months were designated as COVID-19 group. This corresponded to March 10, 2019 – March 10, 2020, for the former and March 11, 2020 – March 11, 2021, for the latter. A 12-month period was determined in order for the change in incidence not to be temporal or seasonal in nature, rather than due to COVID-19.

Statistical analysis. All data were collected into the EXCEL database (Microsoft, Washington, DC, USA). For continuous variables, we calculated and used medians and interquartile ranges. T-test was performed to determine whether there were significant differences between the two groups. Categorical data were reported in numbers and percentages. Analyses to determinate significant differences between the two groups were performed using the Fisher’s exact test in case of dichotomous variable or Monte Carlo test for non-dichotomous variable. Variables with p-values <0.05 were considered statistically significant. Cox regression was used for multivariate analysis. All the statistical analysis was performed in SPSS statistical package version 23.0 (SPSS Inc., Chicago, IL, USA).

Results

From March 11, 2019, to March 11, 2021, 858 patients were admitted to the Emergency Surgical Department at PTV university of Rome Tor Vergata; 524 (61.07%) before the pandemic and 334 (38.93%) during the COVID-19 pandemic. Out of 334 patients admitted during the global pandemic, 36 (10.77%) were admitted with a diagnosis of acute appendicitis versus 59 (11.24%) in the previous year; p=0.911 (30.55%) patients in the COVID-19 group and 26 (44.06%) in the control group were females, p=0.209. Median age was, respectively, 41.4 [26.5-61.9] and 37.1 [28.2-56-4] years during the pandemic and in the previous period, p=0.629.

Among the COVID-19 group, for 27 (75%) patients this was the first admission to the emergency department for acute appendicitis, 7 (19.4%) had a history of a previous admission and 2 patients presented twice or more to the surgical department. Differently, in the pre-pandemic group, 53 (89.8%) were first accesses, 5 (8.5%) a single previous access, and 1 (1.7%) presented two or more accesses to surgical department, showing a statical significant difference: p=0.039.

Median durations between symptomatology onset and admission to healthcare during the pandemic were longer, 2 days [1-4] versus 1 [0-2] in the pre-COVID-19 group, p<0.001. Only 14 (38%) patients underwent preoperative abdominal ultrasound during the pandemic while in the pre-pandemic period, 40 (67.8%) patients received diagnosis of acute appendicitis with sonography method; p=0.008. Moreover, 28 (77.7%) patients in the COVID-19 group and 34 (57.6%) in the pre-COVID-19 underwent abdominal CT scan before surgery, p=0.044.

The Alvarado score showed a statistically significant difference between the groups (p=0.001) and its distribution is resumed in Table I. Admission blood tests are reported in Table II with relative p-values.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Pre-operative Alvarado score between COVID-19 and pre-COVID group.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Blood test between COVID-19 and pre-COVID group.

Surgical procedure duration was longer during the pandemic period with a median of 86 minutes [70-107] versus 60 min [50-80] in the pre-COVID-19 era, showing a statistically significant difference; p<0.001. The surgeon, a senior or a trainee, did not show a difference between the groups with p-value=0.225; 10 procedures (27.8%) were performed by an in-training surgeon during the pandemic and 10 (17.2%) in the control group.

In the COVID-19 group, 30 (83.3%) procedures were performed laparoscopically, 2 (5.6%) conversion in open surgery and 4 (11.1%) cases were performed in upfront open surgery, versus 51(87.9%), 6 (10.3%) and 1 (1.7%), respectively, in the control group; p=0.262.

Intraoperative findings as appendicular abscess, peritonitis, appendicular perforation, and use of abdominal drain tube are resumed in Table III with relative p-values. In addition to the significant increase in peritonitis cases during the pandemic, also the extent of inflammation, depicted by the number of involved abdominal quadrants, was significantly higher with a p<0.001. Abdominal extension of peritonitis and presence of abdominal free fluid and its type are summarized in Table IV. Staging of acute appendicitis at pathological examination was advanced in the pandemic group, showing a statistically significant difference, p<0.001. Pathological classifications of acute appendicitis are resumed in Table V.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Intra-operative findings between COVID-19 and pre-COVID group.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table IV.

Intra-operative peritonitis extension between COVID-19 and pre-COVID group.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table V.

Pathological acute appendicitis classification between COVID-19 and pre-COVID group.

Additionally, methods for closure of appendix stump were significantly different between the groups; p=0.002. During the pandemic we reported an increased use of Endo-GIA staplers; 69.4% versus 36.2% in the control group. One patient in the COVID-19 group received a tobacco pouch suture during an open appendectomy. Contrastingly, closure of appendicular stump using Endo-loops was lower in the COVID-19 group; 13.9% versus 53.4% in the pre-COVID-19 group.

Six months reoperation rates were similar among the groups; p=1.000. One patient (2.8%) underwent a second surgery due to adhesive small bowel obstruction during the pandemic. Differently, in the control group 1 patient (1.7%) underwent right hemicolectomy due to malignancy at pathological examination of appendix. Post-operative blood tests are reported in Table II with relative p-values. Hospital acquired infection rate was 2.8%; 1 patient experienced a mild pneumonia and was discharged in 13th post-operative day, and its length of hospital stay was excluded from the statistical analysis.

Length of hospital stay was longer in the COVID-19 group, with a median of 5 [3-6] days versus 3 [2-4] days in the control group, showing a significant increase with p=0.002. A logistic regression was performed to evaluate the effects of perioperative variables on length of stay. Length of stay was classified as a dummy variable and a median value of 3 was set as the cutoff. All variables with p<0.100 were included in the multivariate analysis. The logistic regression model was statistically significant, χ2(4) = 33.449, p<0.0005. The model explained 42.6% (Nagelkerke R2) of the variance in length of stay and correctly classified 75.9% of cases. Appendicular abscess (p=0.015) and preoperative higher serum level of C reactive protein (p<0.008) were the variables associated with prolonged stay.

Discussion

Since the beginning of SARS-CoV-2 pandemic, routine healthcare and daily life changed dramatically worldwide (24, 25). The pandemic and its consequential restrictions led to high numbers of missed or delayed diagnoses as well as delays in treatment (10-12). Many authors tried to estimate the impact of COVID-19 pandemic on non-COVID-related disease, yet the true extent must still be investigated (15-17, 26). Nowadays, we begin to evaluate the first effects of COVID-19 on non-virus-related diseases (11, 13, 27). In fact, during this emergency period, even access to the surgical emergency department suffered a sharp decline (7, 28-30). Comparably with published data, in our analysis we recorded a reduction of roughly 40% in admissions to the emergency surgical department (28-34). Moreover, the fear of contracting COVID-19 as well as the encouragement by the authorities to avoid unnecessary presentations to the emergency department could explain the reduction in absolute numbers of accesses to the hospital (10, 35).

Differently, median age, sex and incidence did not show significant differences during the different periods. Due to the period comparability, without seasonal or demographic differences between the groups, we did not observe variation in incidence, as similarly reported by numerous studies (36, 37).

Many authors published suggestions on the management of acute appendicitis during the COVID-19 pandemic, advising to favor non-operative management when possible (38, 39). As reported in the literature, non-operative treatment for acute appendicitis presents a variable incidence of recurrence risk (40). In our study, we report a significant increase in the number of previous surgical emergency department accesses for lower right quadrant abdominal pain. This could be potentially explained by the preferred non-operative approach adopted during the pandemic, even in complicated acute appendicitis, leading to an increased recurrence rate before appendectomy. Furthermore, the duration between symptoms onset and admission to healthcare during the pandemic was longer. Probably, the delayed presentation could be related to the fear of contracting COVID-19 and the encouragement from authorities to avoid unnecessary hospital admissions (10, 35, 41). Despite the significantly higher Alvarado score in the Pandemic group, we did not observe a reduction of abdominal imaging prior to surgery. Assumingly, physicians tried to identify as many uncomplicated appendicitis cases as possible in order to apply non-operative management during the pandemic, as suggested in many studies (40-42). Moreover, an increased number of patients was subjected to abdominal CT scans. Although conceptually incorrect, healthcare personnel’s fear of contracting the virus led to the favoring CT scans over abdominal ultrasound in order to reduce contact with the patient as much as possible (9, 42).

Surgical procedure duration was longer during the pandemic period. This could be related to advanced inflammatory processes observed in the COVID-19 group, as reported in our results.

Our analysis, in parallel with studies published in the literature, showed an increased number of intraoperative findings (appendicular abscess, peritonitis and appendicular perforation) as well as higher staging of acute appendicitis on pathological examinations and higher inflammatory indices on blood tests during the pandemic (28, 36). It has been described that patients presenting to the surgical department more than 1 day after the onset of signs and symptoms are at a higher risk of suffering from perforated appendicitis (43, 44). The higher incidence of appendicular perforation could be related to the prolonged duration from the onset of symptoms to treatment.

The use of an abdominal drainage tube was also significantly more frequent in the COVID-19 group. This could be explained by the higher incidence of advanced inflammatory processes, presence of abscess and appendicular perforation observed in our study and other published series (45-47). Due to increased incidence of severe abdominal inflammatory findings and more frequent appendicular perforations, the use of Endo-GIA stapler for securing the appendicular stump was preferred. This is in spite of the lack of a proven superiority over the endo-loop in laparoscopic appendectomy. Additionally, despite higher costs, mechanical suturing was chosen as it is faster and considered safer by many surgeons (48).

Notwithstanding cases with advanced inflammatory processes, no differences were reported in terms of surgical approach; laparoscopic, open or conversion. The choice was based on the acute appendicitis 2020 guidelines, which favor laparoscopic surgery even in complicated cases (49). Despite the increase in difficult cases, the surgeon choice, senior or in training, did not show a difference between the periods. This allowed the training of young surgeons during a challenging period for surgical practice, partly due to the reduction in numbers of surgical procedures (50-52).

Length of hospitalization was significantly higher in the COVID-19 group. The increased cases of complicated appendicitis and the advanced staging of the inflammatory process influenced the hospitalization (53). At multivariate analysis, appendicular abscess and plasma levels of C reactive protein seemed to be the major factors influencing hospitalization (53, 54). Our findings are in accordance with a recent report by Sevinç et al. (55).

There are several limitations to our study; the first wave of the COVID-19 pandemic was unexpected, and the healthcare system was not prepared to simultaneously provide care for COVID-19 and non-virus-related patients. This has likely led to guidelines not being followed at times, especially at the beginning of the pandemic when there were no suggestions for the management of acute appendicitis during the COVID-19 pandemic. Additionally, this is a single institution, retrospective analysis that was performed utilizing ICD codes in order to identify every patient with the diagnosis of acute appendicitis. Finally, the small number of patients admitted with acute appendicitis represented an intrinsic limitation.

In conclusion, this study highlights the direct correlation between COVID-19 pandemic and the severity of acute appendicitis presentations. The significant increase in the incidence of complicated acute appendicitis with advanced inflammatory processes and in longer hospitalization times indicates that these patients required earlier diagnosis and treatment. In light of the high healthcare costs associated with appendicitis hospitalization, the resources transferred to COVID-19 patients thus far and the likelihood of further COVID-19 waves, it is prudent to address these issues so that this does not reoccur.

Footnotes

  • Authors’ Contributions

    Study conception and design: Marco Pellicciaro; Acquisition of data: Francesca Santori and Simona Grande; Analysis of data: Marco Pellicciaro and Marco Materazzo; Interpretation of data: Gianluca Vanni, Daniele Sforza, Di Cesare Tataiana, Ciancio Manuelli Matteo; Drafting of article: Marco Pellicciaro, Dario Venditti and Massimo Villa; Critical revision of literature: Marco Pellicciaro, Dario Venditti and Marco Materazzo. Clinical Case data acquisition: Gianluca Vanni, Daniele Sforza, Di Cesare Tatiana, Ciancio Manuelli Matteo. Supervision: Michele Grande. All the Authors read and approved the final version of the manuscript.

  • Conflicts of Interest

    The Authors declare no conflicts of interest regarding this study.

  • Received January 3, 2022.
  • Revision received January 24, 2022.
  • Accepted February 16, 2022.
  • Copyright © 2022 The Author(s). Published by the International Institute of Anticancer Research.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

References

  1. ↵
    1. Andersen KG,
    2. Rambaut A,
    3. Lipkin WI,
    4. Holmes EC and
    5. Garry RF
    : The proximal origin of SARS-CoV-2. Nat Med 26(4): 450-452, 2020. PMID: 32284615. DOI: 10.1038/s41591-020-0820-9
    OpenUrlCrossRefPubMed
  2. ↵
    1. Guan WJ,
    2. Ni ZY,
    3. Hu Y,
    4. Liang WH,
    5. Ou CQ,
    6. He JX,
    7. Liu L,
    8. Shan H,
    9. Lei CL,
    10. Hui DSC,
    11. Du B,
    12. Li LJ,
    13. Zeng G,
    14. Yuen KY,
    15. Chen RC,
    16. Tang CL,
    17. Wang T,
    18. Chen PY,
    19. Xiang J,
    20. Li SY,
    21. Wang JL,
    22. Liang ZJ,
    23. Peng YX,
    24. Wei L,
    25. Liu Y,
    26. Hu YH,
    27. Peng P,
    28. Wang JM,
    29. Liu JY,
    30. Chen Z,
    31. Li G,
    32. Zheng ZJ,
    33. Qiu SQ,
    34. Luo J,
    35. Ye CJ,
    36. Zhu SY,
    37. Zhong NS
    and China Medical Treatment Expert Group for Covid-19: Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 382(18): 1708-1720, 2020. PMID: 32109013. DOI: 10.1056/NEJMoa2002032
    OpenUrlCrossRefPubMed
  3. ↵
    1. Vanni G,
    2. Pellicciaro M,
    3. Materazzo M,
    4. Palombi L and
    5. Buonomo OC
    : Breast cancer diagnosis in Coronavirus-era: alert from Italy. Front Oncol 10: 938, 2020. PMID: 32574281. DOI: 10.3389/fonc.2020.00938
    OpenUrlCrossRefPubMed
  4. ↵
    1. Vanni G,
    2. Tazzioli G,
    3. Pellicciaro M,
    4. Materazzo M,
    5. Paolo O,
    6. Cattadori F,
    7. Combi F,
    8. Papi S,
    9. Pistolese CA,
    10. Cotesta M,
    11. Santori F,
    12. Caspi J,
    13. Chiaravalloti A,
    14. Muscoli S,
    15. Lombardo V,
    16. Grasso A,
    17. Caggiati L,
    18. Raselli R,
    19. Palli D,
    20. Altomare V, D’
    21. Angelillo RM,
    22. Palombi L and
    23. Buonomo OC
    : Delay in breast cancer treatments during the first COVID-19 lockdown. a multicentric analysis of 432 patients. Anticancer Res 40(12): 7119-7125, 2020. PMID: 33288611. DOI: 10.21873/anticanres.14741
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Vanni G,
    2. Pellicciaro M,
    3. Materazzo M,
    4. Dauri M, D’angelillo RM,
    5. Buonomo C,
    6. De Majo A,
    7. Pistolese C,
    8. Portarena I,
    9. Mauriello A,
    10. Servadei F,
    11. Giacobbi E,
    12. Chiaravalloti A and
    13. Buonomo OC
    : Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency. Breast Cancer 28(1): 137-144, 2021. PMID: 32734327. DOI: 10.1007/s12282-020-01137-5
    OpenUrlCrossRefPubMed
  6. ↵
    1. Vanni G,
    2. Materazzo M,
    3. Pellicciaro M,
    4. Caspi J,
    5. Capacci A and
    6. Merra G
    : Access to health care after COVID-19 pandemic: is it time for telemedicine? Eur Rev Med Pharmacol Sci 24(19): 9778-9779, 2020. PMID: 33090451. DOI: 10.26355/eurrev_202010_23185
    OpenUrlCrossRefPubMed
  7. ↵
    1. Vanni G,
    2. Legramante JM,
    3. Pellicciaro M,
    4. DE Carolis G,
    5. Cotesta M,
    6. Materazzo M,
    7. Buonomo C,
    8. Farinaccio A,
    9. Santori F,
    10. Saraceno F,
    11. Ielpo B,
    12. Aiello F,
    13. Paganelli C,
    14. Grande M,
    15. DE Andreis G,
    16. Chiocchi M,
    17. Palombi L and
    18. Buonomo OC
    : Effect of lockdown in surgical emergency accesses: experience of a COVID-19 hospital. In Vivo 34(5): 3033-3038, 2020. PMID: 32871849. DOI: 10.21873/invivo.12137
    OpenUrlAbstract/FREE Full Text
    1. Farchi S,
    2. Polo A,
    3. Lacalamita M,
    4. Spiga G, Ribaldi and
    5. Davoli M
    : Access to the emergency at times of COVID-19: an analysis of the first three months in the Lazio region. Available at: https://repo.epiprev.it/index.php/download/laccesso-al-pronto-soccorso-ai-tempi-del-covid-19-una-analisi-dei-primi-tre-mesi-nella-regione-lazio/ [Last accessed on February 16, 2022]
  8. ↵
    1. Vanni G,
    2. Materazzo M,
    3. Santori F,
    4. Pellicciaro M,
    5. Costesta M,
    6. Orsaria P,
    7. Cattadori F,
    8. Pistolese CA,
    9. Perretta T,
    10. Chiocchi M,
    11. Meucci R,
    12. Lamacchia F,
    13. Assogna M,
    14. Caspi J,
    15. Granai AV,
    16. DE Majo A,
    17. Chiaravalloti A, D’
    18. Angelillo MR,
    19. Barbarino R,
    20. Ingallinella S,
    21. Morando L,
    22. Dalli S,
    23. Portarena I,
    24. Altomare V,
    25. Tazzioli G and
    26. Buonomo OC
    : The effect of Coronavirus (COVID-19) on breast cancer teamwork: a multicentric survey. In Vivo 34(3 Suppl): 1685-1694, 2020. PMID: 32503830. DOI: 10.21873/invivo.11962
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Lazzerini M,
    2. Barbi E,
    3. Apicella A,
    4. Marchetti F,
    5. Cardinale F and
    6. Trobia G
    : Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health 4(5): e10-e11, 2020. PMID: 32278365. DOI: 10.1016/S2352-4642(20)30108-5
    OpenUrlCrossRefPubMed
  10. ↵
    1. Vanni G,
    2. Pellicciaro M,
    3. Combi F,
    4. Papi S,
    5. Materazzo M,
    6. Segattini S,
    7. Rizza S,
    8. Chiocchi M,
    9. Perretta T,
    10. Meucci R,
    11. Portarena I,
    12. Pistolese CA,
    13. Ielpo B,
    14. Campanelli M,
    15. Lisi G,
    16. Chiaravalloti A,
    17. Tazzioli G and
    18. Buonomo OC
    : Impact of COVID-19 pandemic on surgical breast cancer patients undergoing neoadjuvant therapy: a multicentric study. Anticancer Res 41(9): 4535-4542, 2021. PMID: 34475080. DOI: 10.21873/anticanres.15265
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Vanni G,
    2. Pellicciaro M,
    3. Materazzo M,
    4. Pedini D,
    5. Portarena I,
    6. Buonomo C,
    7. Perretta T,
    8. Rizza S,
    9. Pistolese CA and
    10. Buonomo OC
    : Advanced stages and increased need for adjuvant treatments in breast cancer patients: the effect of the one-year COVID-19 pandemic. Anticancer Res 41(5): 2689-2696, 2021. PMID: 33952500. DOI: 10.21873/anticanres.15050
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Vanni G,
    2. Santori F,
    3. Pellicciaro M,
    4. Materazzo M,
    5. Caspi J,
    6. Granai AV,
    7. DE Majo A,
    8. Servadei F,
    9. Giacobbi E,
    10. Perretta T,
    11. Meucci R,
    12. Pistolese CA and
    13. Buonomo OC
    : Extremely advanced breast cancer presentation: possible effect of Coronavirus pandemic anxiety. In Vivo 35(4): 2331-2335, 2021. PMID: 34182514. DOI: 10.21873/invivo.12508
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Ielpo B,
    2. Pernaute AS,
    3. Elia S,
    4. Buonomo OC,
    5. Valladares LD,
    6. Aguirre EP,
    7. Petrella G and
    8. Garcia AT
    : Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction. Interact Cardiovasc Thorac Surg 10(5): 704-708, 2010. PMID: 20154347. DOI: 10.1510/icvts.2009.222778
    OpenUrlCrossRefPubMed
  14. ↵
    1. Tankel J,
    2. Keinan A,
    3. Blich O,
    4. Koussa M,
    5. Helou B,
    6. Shay S,
    7. Zugayar D,
    8. Pikarsky A,
    9. Mazeh H,
    10. Spira R and
    11. Reissman P
    : The decreasing incidence of acute appendicitis during COVID-19: a retrospective multi-centre study. World J Surg 44(8): 2458-2463, 2020. PMID: 32458019. DOI: 10.1007/s00268-020-05599-8
    OpenUrlCrossRefPubMed
    1. Cammalleri V,
    2. Muscoli S,
    3. Benedetto D,
    4. Stifano G,
    5. Macrini M,
    6. Di Landro A,
    7. Di Luozzo M,
    8. Marchei M,
    9. Mariano EG,
    10. Cota L,
    11. Sergi D,
    12. Bezzeccheri A,
    13. Bonanni M,
    14. Baluci M,
    15. De Vico P and
    16. Romeo F
    : Who has seen patients with ST-segment-elevation myocardial infarction? First results from Italian real-world Coronavirus disease 2019. J Am Heart Assoc 9(19): e017126, 2020. PMID: 32901560. DOI: 10.1161/JAHA.120.017126
    OpenUrlCrossRefPubMed
  15. ↵
    1. Aiello F,
    2. Genzano Besso F,
    3. Pocobelli G,
    4. Gallo Afflitto G,
    5. Colabelli Gisoldi RAM,
    6. Nucci C,
    7. Ponzin D
    and Italian Society Eye Bank Group (SIBO): Corneal transplant during COVID-19 pandemic: the Italian Eye Bank national report. Cell Tissue Bank 22(4): 697-702, 2021. PMID: 34028630. DOI: 10.1007/s10561-021-09934-8
    OpenUrlCrossRefPubMed
  16. ↵
    1. Cervellin G,
    2. Mora R,
    3. Ticinesi A,
    4. Meschi T,
    5. Comelli I,
    6. Catena F and
    7. Lippi G
    : Epidemiology and outcomes of acute abdominal pain in a large urban Emergency Department: retrospective analysis of 5,340 cases. Ann Transl Med 4(19): 362, 2016. PMID: 27826565. DOI: 10.21037/atm.2016.09.10
    OpenUrlCrossRefPubMed
  17. ↵
    1. Ielpo B,
    2. Mazzetti C,
    3. Venditti D,
    4. Buonomo O and
    5. Petrella G
    : A case of metachronous splenic metastasis from renal cell carcinoma after 14 years. Int J Surg 8(5): 353-355, 2010. PMID: 20438874. DOI: 10.1016/j.ijsu.2010.04.006
    OpenUrlCrossRefPubMed
  18. ↵
    1. Roselli M,
    2. Guadagni F,
    3. Buonomo O,
    4. Belardi A,
    5. Ferroni P,
    6. Diodati A,
    7. Anselmi D,
    8. Cipriani C,
    9. Casciani CU,
    10. Greiner J and
    11. Schlom J
    : Tumor markers as targets for selective diagnostic and therapeutic procedures. Anticancer Res 16(4B): 2187-2192, 1996. PMID: 8694541.
    OpenUrlPubMed
  19. ↵
    1. Anselmo A,
    2. Iaria G,
    3. Pellicciaro M,
    4. Sforza D,
    5. Parente A,
    6. Campisi A,
    7. Cacciatore C,
    8. Calafiore E,
    9. Pisani G and
    10. Tisone G
    : Native nephrectomy in patients with autosomal dominant polycystic kidney disease evaluated for kidney transplantation. Transplant Proc 51(9): 2914-2916, 2019. PMID: 31711576. DOI: 10.1016/j.transproceed.2019.08.010
    OpenUrlCrossRefPubMed
    1. Angelico R,
    2. Pietrobattista A,
    3. Candusso M,
    4. Tomarchio S,
    5. Pellicciaro M,
    6. Liccardo D,
    7. Basso MS,
    8. Grimaldi C,
    9. Saffioti MC,
    10. Torroni F,
    11. Dall’Oglio L,
    12. Torre G and
    13. Spada M
    : Primary prophylaxis for gastrointestinal bleeding in children with biliary atresia and portal hypertension candidates for liver transplantation: a single-center experience. Transplant Proc 51(1): 171-178, 2019. PMID: 30655149. DOI: 10.1016/j.transproceed.2018.04.074
    OpenUrlCrossRefPubMed
    1. Alvarado A
    : A practical score for the early diagnosis of acute appendicitis. Ann Emerg Med 15(5): 557-564, 1986. PMID: 3963537. DOI: 10.1016/s0196-0644(86)80993-3
    OpenUrlCrossRefPubMed
  20. ↵
    1. Vanni G,
    2. Materazzo M,
    3. Perretta T,
    4. Meucci R,
    5. Anemona L,
    6. Buonomo C,
    7. Dauri M,
    8. Granai AV,
    9. Rho M,
    10. Ingallinella S,
    11. Tacconi F,
    12. Ambrogi V,
    13. Chiaravalloti A,
    14. Schillaci O,
    15. Petrella G and
    16. Buonomo OC
    : Impact of awake breast cancer surgery on postoperative lymphocyte responses. In Vivo 33(6): 1879-1884, 2019. PMID: 31662515. DOI: 10.21873/invivo.11681
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Vanni G,
    2. Pellicciaro M,
    3. Materazzo M,
    4. Bruno V,
    5. Oldani C,
    6. Pistolese CA,
    7. Buonomo C,
    8. Caspi J,
    9. Gualtieri P,
    10. Chiaravalloti A,
    11. Palombi L,
    12. Piccione E and
    13. Buonomo OC
    : Lockdown of breast cancer screening for COVID-19: possible scenario. In Vivo 34(5): 3047-3053, 2020. PMID: 32871851. DOI: 10.21873/invivo.12139
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Buonomo O,
    2. Granai AV,
    3. Felici A,
    4. Piccirillo R,
    5. De Liguori Carino N,
    6. Guadagni F,
    7. Polzoni M,
    8. Mariotti S,
    9. Cipriani C,
    10. Simonetti G,
    11. Cossu E,
    12. Schiaroli S,
    13. Altomare V,
    14. Cabassi A,
    15. Pernazza E,
    16. Casciani CU and
    17. Roselli M
    : Day-surgical management of ductal carcinoma in situ (DCIS) of the breast using wide local excision with sentinel node biopsy. Tumori 88(3): S48-S49, 2002. PMID: 12365390.
    OpenUrlPubMed
  23. ↵
    1. Pellicciaro M,
    2. Granai AV,
    3. Marchese G,
    4. Materazzo M,
    5. Cotesta M,
    6. Santori F,
    7. Giacobbi E,
    8. Servadei F,
    9. Grelli S,
    10. Perretta T,
    11. Meucci R,
    12. Pistolese CA and
    13. Vanni G
    : Breast cancer patients with hormone neoadjuvant bridging therapy due to asymptomatic Corona virus infection. Case report, clinical and histopathologic findings. Int J Surg Case Rep 76: 377-380, 2020. PMID: 33052300. DOI: 10.1016/j.ijscr.2020.10.020
    OpenUrlCrossRefPubMed
  24. ↵
    1. Vissio E,
    2. Falco EC,
    3. Scozzari G,
    4. Scarmozzino A,
    5. Trinh DAA,
    6. Morino M,
    7. Papotti M,
    8. Bertero L and
    9. Cassoni P
    : The adverse impact of the COVID-19 pandemic on abdominal emergencies: a retrospective clinico-pathological analysis. J Clin Med 10(22): 5254, 2021. PMID: 34830534. DOI: 10.3390/jcm10225254
    OpenUrlCrossRefPubMed
    1. Buonomo O,
    2. Cabassi A,
    3. Guadagni F,
    4. Piazza A,
    5. Felici A,
    6. Piccirillo R,
    7. Atzei GP,
    8. Cipriani C,
    9. Schiaroli S,
    10. Mariotti S,
    11. Guazzaroni MN,
    12. Cossu E,
    13. Simonetti G,
    14. Pernazza E,
    15. Casciani CU and
    16. Roselli M
    : Radioguided-surgery of early breast lesions. Anticancer Res 21(3C): 2091-2097, 2001. PMID: 11501831.
    OpenUrlPubMed
  25. ↵
    1. Köhler F,
    2. Acar L,
    3. van den Berg A,
    4. Flemming S,
    5. Kastner C,
    6. Müller S,
    7. Diers J,
    8. Germer CT,
    9. Lock JF,
    10. L’hoest H,
    11. Marschall U and
    12. Wiegering A
    : Impact of the COVID-19 pandemic on appendicitis treatment in Germany-a population-based analysis. Langenbecks Arch Surg 406(2): 377-383, 2021. PMID: 33420517. DOI: 10.1007/s00423-021-02081-4
    OpenUrlCrossRefPubMed
    1. Head WT,
    2. Parrado RH and
    3. Cina RA
    : Impact of the Coronavirus (COVID-19) pandemic on the care of pediatric acute appendicitis. Am Surg: 31348211067995, 2021. PMID: 34957861. DOI: 10.1177/00031348211067995
    OpenUrlCrossRefPubMed
    1. Rudnicki Y,
    2. Soback H,
    3. Mekiten O,
    4. Lifshiz G and
    5. Avital S
    : The impact of COVID-19 pandemic lockdown on the incidence and outcome of complicated appendicitis. Surg Endosc: 1-7, 2021. PMID: 34312724. DOI: 10.1007/s00464-021-08667-9
    OpenUrlCrossRefPubMed
    1. Amelio I,
    2. Bertolo R,
    3. Bove P,
    4. Buonomo OC,
    5. Candi E,
    6. Chiocchi M,
    7. Cipriani C,
    8. Di Daniele N,
    9. Ganini C,
    10. Juhl H,
    11. Mauriello A,
    12. Marani C,
    13. Marshall J,
    14. Montanaro M,
    15. Palmieri G,
    16. Piacentini M,
    17. Sica G,
    18. Tesauro M,
    19. Rovella V,
    20. Tisone G,
    21. Shi Y,
    22. Wang Y and
    23. Melino G
    : Liquid biopsies and cancer omics. Cell Death Discov 6(1): 131, 2020. PMID: 33298891. DOI: 10.1038/s41420-020-00373-0
    OpenUrlCrossRefPubMed
  26. ↵
    1. Scheijmans JCG,
    2. Borgstein ABJ,
    3. Puylaert CAJ,
    4. Bom WJ,
    5. Bachiri S,
    6. van Bodegraven EA,
    7. Brandsma ATA,
    8. Ter Brugge FM,
    9. de Castro SMM,
    10. Couvreur R,
    11. Franken LC,
    12. Gaspersz MP,
    13. de Graaff MR,
    14. Groenen H,
    15. Kleipool SC,
    16. Kuypers TJL,
    17. Martens MH,
    18. Mens DM,
    19. Orsini RG,
    20. Reneerkens NJMM,
    21. Schok T,
    22. Sedee WJA,
    23. Tavakoli Rad S,
    24. Volders JH,
    25. Weeder PD,
    26. Prins JM,
    27. Gietema HA,
    28. Stoker J,
    29. Gisbertz SS,
    30. Besselink MGH,
    31. Boermeester MA
    and SCOUT Collaboarative Study group: Impact of the COVID-19 pandemic on incidence and severity of acute appendicitis: a comparison between 2019 and 2020. BMC Emerg Med 21(1): 61, 2021. PMID: 33980150. DOI: 10.1186/s12873-021-00454-y
    OpenUrlCrossRefPubMed
  27. ↵
    1. Wong L,
    2. Hawkins J,
    3. Langness S,
    4. Murrel KL,
    5. Iris P and
    6. Sammann A
    : Where are all the patients? Addressing covid-19 fear to encourage sick patients to seek emergency care. NEJM Catalyst, Innovations in Care Delivery, 2020. DOI: 10.1056/CAT.20.0193. Available at: https://catalyst.nejm.org/doi/full/10.1056/CAT.20.0193 [Last accessed on February 16, 2022]
    OpenUrlCrossRef
  28. ↵
    1. Yoshimoto H,
    2. Yamakawa K,
    3. Umemura Y,
    4. Fujii K,
    5. Nakamura E,
    6. Taniguchi K,
    7. Tanaka K,
    8. Takasu A and
    9. Uchiyama K
    : Seasonal variation and severity of acute abdomen in Japan: A nine-year retrospective analysis. J Pers Med 11(12): 1346, 2021. PMID: 34945818. DOI: 10.3390/jpm11121346
    OpenUrlCrossRefPubMed
  29. ↵
    1. Farber ON,
    2. Gomez GI,
    3. Titan AL,
    4. Fisher AT,
    5. Puntasecca CJ,
    6. Arana VT,
    7. Kempinsky A,
    8. Wise CE,
    9. Bessoff KE,
    10. Hawn MT,
    11. Korndorffer JR Jr.,
    12. Forrester JD and
    13. Esquivel MM
    : Impact of COVID-19 on presentation, management, and outcomes of acute care surgery for gallbladder disease and acute appendicitis. World J Gastrointest Surg 13(8): 859-870, 2021. PMID: 34512909. DOI: 10.4240/wjgs.v13.i8.859
    OpenUrlCrossRefPubMed
  30. ↵
    1. Emile SH,
    2. Hamid HKS,
    3. Khan SM and
    4. Davis GN
    : Rate of application and outcome of non-operative management of acute appendicitis in the setting of COVID-19: systematic review and meta-analysis. J Gastrointest Surg 25(7): 1905-1915, 2021. PMID: 33772399. DOI: 10.1007/s11605-021-04988-1
    OpenUrlCrossRefPubMed
  31. ↵
    1. Kvasnovsky CL,
    2. Shi Y,
    3. Rich BS,
    4. Glick RD,
    5. Soffer SZ,
    6. Lipskar AM,
    7. Dolgin S,
    8. Bagrodia N,
    9. Hong A,
    10. Prince JM,
    11. James DE and
    12. Sathya C
    : Limiting hospital resources for acute appendicitis in children: Lessons learned from the U.S. epicenter of the COVID-19 pandemic. J Pediatr Surg 56(5): 900-904, 2021. PMID: 32620267. DOI: 10.1016/j.jpedsurg.2020.06.024
    OpenUrlCrossRefPubMed
  32. ↵
    1. Di Saverio S,
    2. Sibilio A,
    3. Giorgini E,
    4. Biscardi A,
    5. Villani S,
    6. Coccolini F,
    7. Smerieri N,
    8. Pisano M,
    9. Ansaloni L,
    10. Sartelli M,
    11. Catena F and
    12. Tugnoli G
    : The NOTA Study (Non Operative Treatment for Acute Appendicitis): prospective study on the efficacy and safety of antibiotics (amoxicillin and clavulanic acid) for treating patients with right lower quadrant abdominal pain and long-term follow-up of conservatively treated suspected appendicitis. Ann Surg 260(1): 109-117, 2014. PMID: 24646528. DOI: 10.1097/SLA.0000000000000560
    OpenUrlCrossRefPubMed
  33. ↵
    1. Vanni G,
    2. Materazzo M,
    3. Pellicciaro M,
    4. Ingallinella S,
    5. Rho M,
    6. Santori F,
    7. Cotesta M,
    8. Caspi J,
    9. Makarova A,
    10. Pistolese CA and
    11. Buonomo OC
    : Breast cancer and COVID-19: The effect of fear on patients’ decision-making process. In Vivo 34(3 Suppl): 1651-1659, 2020. PMID: 32503825. DOI: 10.21873/invivo.11957
    OpenUrlAbstract/FREE Full Text
  34. ↵
    1. Podda M,
    2. Pata F,
    3. Pellino G,
    4. Ielpo B and
    5. Di Saverio S
    : Acute appendicitis during the COVID-19 lockdown: never waste a crisis! Br J Surg 108(1): e31-e32, 2021. PMID: 33640949. DOI: 10.1093/bjs/znaa073
    OpenUrlCrossRefPubMed
  35. ↵
    1. Williams N and
    2. Bello M
    : Perforation rate relates to delayed presentation in childhood acute appendicitis. J R Coll Surg Edinb 43(2): 101-102, 1998. PMID: 9621533.
    OpenUrlPubMed
  36. ↵
    1. Kearney D,
    2. Cahill RA, O’
    3. Brien E,
    4. Kirwan WO and
    5. Redmond HP
    : Influence of delays on perforation risk in adults with acute appendicitis. Dis Colon Rectum 51(12): 1823-1827, 2008. PMID: 18584252. DOI: 10.1007/s10350-008-9373-6
    OpenUrlCrossRefPubMed
  37. ↵
    1. Finkelstein P,
    2. Picado O,
    3. Muddasani K,
    4. Wodnicki H,
    5. Mesko T,
    6. Unger S,
    7. Bao P,
    8. Jorge I,
    9. Narayanan S and
    10. Ben-David K
    : A retrospective analysis of the trends in acute appendicitis during the COVID-19 pandemic. J Laparoendosc Adv Surg Tech A 31(3): 243-246, 2021. PMID: 33181062. DOI: 10.1089/lap.2020.0749
    OpenUrlCrossRefPubMed
    1. Fisher JC,
    2. Tomita SS,
    3. Ginsburg HB,
    4. Gordon A,
    5. Walker D and
    6. Kuenzler KA
    : Increase in pediatric perforated appendicitis in the New York City Metropolitan region at the epicenter of the COVID-19 outbreak. Ann Surg 273(3): 410-415, 2021. PMID: 32976285. DOI: 10.1097/SLA.0000000000004426
    OpenUrlCrossRefPubMed
  38. ↵
    1. Orthopoulos G,
    2. Santone E,
    3. Izzo F,
    4. Tirabassi M,
    5. Pérez-Caraballo AM,
    6. Corriveau N and
    7. Jabbour N
    : Increasing incidence of complicated appendicitis during COVID-19 pandemic. Am J Surg 221(5): 1056-1060, 2021. PMID: 33012500. DOI: 10.1016/j.amjsurg.2020.09.026
    OpenUrlCrossRefPubMed
  39. ↵
    1. van Rossem CC,
    2. van Geloven AA,
    3. Schreinemacher MH,
    4. Bemelman WA and snapshot appendicitis collaborative study group
    : Endoloops or endostapler use in laparoscopic appendectomy for acute uncomplicated and complicated appendicitis : No difference in infectious complications. Surg Endosc 31(1): 178-184, 2017. PMID: 27129569. DOI: 10.1007/s00464-016-4951-5
    OpenUrlCrossRefPubMed
  40. ↵
    1. Di Saverio S,
    2. Podda M,
    3. De Simone B,
    4. Ceresoli M,
    5. Augustin G,
    6. Gori A,
    7. Boermeester M,
    8. Sartelli M,
    9. Coccolini F,
    10. Tarasconi A,
    11. De’ Angelis N,
    12. Weber DG,
    13. Tolonen M,
    14. Birindelli A,
    15. Biffl W,
    16. Moore EE,
    17. Kelly M,
    18. Soreide K,
    19. Kashuk J,
    20. Ten Broek R,
    21. Gomes CA,
    22. Sugrue M,
    23. Davies RJ,
    24. Damaskos D,
    25. Leppäniemi A,
    26. Kirkpatrick A,
    27. Peitzman AB,
    28. Fraga GP,
    29. Maier RV,
    30. Coimbra R,
    31. Chiarugi M,
    32. Sganga G,
    33. Pisanu A,
    34. De’ Angelis GL,
    35. Tan E,
    36. Van Goor H,
    37. Pata F,
    38. Di Carlo I,
    39. Chiara O,
    40. Litvin A,
    41. Campanile FC,
    42. Sakakushev B,
    43. Tomadze G,
    44. Demetrashvili Z,
    45. Latifi R,
    46. Abu-Zidan F,
    47. Romeo O,
    48. Segovia-Lohse H,
    49. Baiocchi G,
    50. Costa D,
    51. Rizoli S,
    52. Balogh ZJ,
    53. Bendinelli C,
    54. Scalea T,
    55. Ivatury R,
    56. Velmahos G,
    57. Andersson R,
    58. Kluger Y,
    59. Ansaloni L and
    60. Catena F
    : Diagnosis and treatment of acute appendicitis: 2020 update of the WSES Jerusalem guidelines. World J Emerg Surg 15(1): 27, 2020. PMID: 32295644. DOI: 10.1186/s13017-020-00306-3
    OpenUrlCrossRefPubMed
  41. ↵
    1. Khan KS,
    2. Keay R, McLellan M and
    3. Mahmud S
    : Impact of the COVID-19 pandemic on core surgical training. Scott Med J 65(4): 133-137, 2020. PMID: 32772846. DOI: 10.1177/0036933020949217
    OpenUrlCrossRefPubMed
    1. Doulias T,
    2. Gallo G,
    3. Rubio-Perez I,
    4. Breukink SO and
    5. Hahnloser D
    : Doing more with less: surgical training in the COVID-19 era. J Invest Surg 35(1): 171-179, 2022. PMID: 32959688. DOI: 10.1080/08941939.2020.1824250
    OpenUrlCrossRefPubMed
  42. ↵
    1. Collins C,
    2. Mahuron K,
    3. Bongiovanni T,
    4. Lancaster E,
    5. Sosa JA and
    6. Wick E
    : Stress and the surgical resident in the COVID-19 pandemic. J Surg Educ 78(2): 422-430, 2021. PMID: 32792326. DOI: 10.1016/j.jsurg.2020.07.031
    OpenUrlCrossRefPubMed
  43. ↵
    1. Ximenes AM,
    2. Mello FS, Lima-Júnior ZB,
    3. Ferreira CF,
    4. Cavalcanti AD and
    5. Dias-Filho AV
    : Hospitalization time after open appendectomy by three different surgical techniques. Arq Bras Cir Dig 27(3): 188-190, 2014. PMID: 25184769. DOI: 10.1590/s0102-67202014000300007
    OpenUrlCrossRefPubMed
  44. ↵
    1. Gavela T,
    2. Cabeza B,
    3. Serrano A and
    4. Casado-Flores J
    : C-reactive protein and procalcitonin are predictors of the severity of acute appendicitis in children. Pediatr Emerg Care 28(5): 416-419, 2012. PMID: 22531196. DOI: 10.1097/PEC.0b013e318252d875
    OpenUrlCrossRefPubMed
  45. ↵
    1. Okuş A,
    2. Ay S,
    3. Karahan Ö,
    4. Eryilmaz MA,
    5. Sevinç B and
    6. Aksoy N
    : Monitoring C-reactive protein levels during medical management of acute appendicitis to predict the need for surgery. Surg Today 45(4): 451-456, 2015. PMID: 25542081. DOI: 10.1007/s00595-014-1099-6
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

In Vivo
Vol. 36, Issue 3
May-June 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Acute Appendicitis During Coronavirus Disease 2019 (COVID-19): Increasing Incidence of Complicate Appendicitis, Severity and Length of Hospitalization
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 16 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Acute Appendicitis During Coronavirus Disease 2019 (COVID-19): Increasing Incidence of Complicate Appendicitis, Severity and Length of Hospitalization
MARCO PELLICCIARO, GIANLUCA VANNI, SIMONA GRANDE, MARCO MATERAZZO, FRANCESCA SANTORI, TATIANA DI CESARE, MATTEO CIANCIO MANUELLI, DANIELE SFORZA, MASSIMO VILLA, DARIO VENDITTI, MICHELE GRANDE
In Vivo May 2022, 36 (3) 1325-1332; DOI: 10.21873/invivo.12833

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Acute Appendicitis During Coronavirus Disease 2019 (COVID-19): Increasing Incidence of Complicate Appendicitis, Severity and Length of Hospitalization
MARCO PELLICCIARO, GIANLUCA VANNI, SIMONA GRANDE, MARCO MATERAZZO, FRANCESCA SANTORI, TATIANA DI CESARE, MATTEO CIANCIO MANUELLI, DANIELE SFORZA, MASSIMO VILLA, DARIO VENDITTI, MICHELE GRANDE
In Vivo May 2022, 36 (3) 1325-1332; DOI: 10.21873/invivo.12833
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Awake Breast Conservative Surgery: A Strategy to Shorten Surgical Waiting Lists During and Post COVID-19 Emergency
  • Google Scholar

More in this TOC Section

  • Risk Factors and Clinical Significance of Grade ≥3 Neutropenia During the First Cycle of Cabazitaxel Therapy With Primary Pegfilgrastim Prophylaxis in Metastatic Castration-resistant Prostate Cancer
  • Impact of Donor Cirrhosis Outcome Risk Estimator (CORE) Score on Recipient Outcomes Following Living-donor Liver Transplantation
  • The Clinical Impact of Textbook Outcome in Patients With Stage 1 Gastric Cancer Who Received Laparoscopy-assisted Gastrectomy or Robotic-assisted Gastrectomy
Show more Clinical Studies

Keywords

  • Acute appendicitis
  • COVID-19
  • SARS-CoV-2
  • occult disease
  • appendectomy
  • peritonitis
In Vivo

© 2026 In Vivo

Powered by HighWire